Amanote Research
Register
Sign In
P53 Expression and K-Ras Mutation in Colorectal Adenomas.
Gut
- United Kingdom
doi 10.1136/gut.34.5.621
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gastroenterology
Date
May 1, 1993
Authors
N Scott
S M Bell
P Sagar
G E Blair
M F Dixon
P Quirke
Publisher
BMJ
Related search
Increased Frequency of the K-Ras G12C Mutation in MYH Polyposis Colorectal Adenomas
British Journal of Cancer
Cancer Research
Oncology
Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation
OncoTargets and Therapy
Oncology
Pharmacology
Expression of Ras-P21 in Normal Salivary Glands and Pleomor Phic Adenomas.
Japanese Journal of Oral Biology
K-Ras and P53 Mutations in Association With COX-2 and Htert Expression and Clinico-Pathological Status of NSCLC Patients
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Mutation Status Matters: RAS, P53, and Targeting Autophagy as a Potential Strategy in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Tumor Protein P53 and K-Ras Gene Mutations in Peruvian Patients With Gallbladder Cancer
Asian Pacific Journal of Cancer Prevention
Gut Microbiome and Colorectal Adenomas
Cancer Journal
Cancer Research
Oncology
Usefulness of P53 Gene Mutations in the Supernatant of Bile for Diagnosis of Biliary Tract Carcinoma: Comparison With K- Ras Mutation
Journal of Gastroenterology
Gastroenterology
Antisense Gene Therapy Using Anti-K-Ras and Antitelomerase Oligonucleotides in Colorectal Cancer
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology